RSV program cancelled?

[Anonymous]

I got an alert that Gilead pulled back on the RSV (severe cold for babies) clinical study they were supposed to run. I hope this isn't another product biting the dust.

 

[Anonymous]

I got an alert that Gilead pulled back on the RSV (severe cold for babies) clinical study they were supposed to run. I hope this isn't another product biting the dust.

There is a problem with the IP. We need to get that settled first.

 

[Anonymous]

There is a problem with the IP. We need to get that settled first.

First we need to get that out of the way then we can study this fusion inhibitor.

 

[Anonymous]

Or will give them back their RS-637 and good riddance.

 

[Anonymous]

Or will give them back their RS-637 and good riddance.

Actually, we are still trying to get thru the IP hurdles with our next Superstar Product. its giving me a headache.

 

[Berkshire]

What IP hurdles?

 

[Anonymous]

I don't think the Gilead molecule is RS 637. This one is GS-5806. I think they gave up on RS 637 awhile back.